Enanta Pharmaceuticals (NASDAQ:ENTA)

CAPS Rating: 4 out of 5

Caps

How do you think ENTA will perform against the market?

Add Stock to CAPS Watchlist

All Players

91 Outperform
2 Underperform
 

All-Star Players

25 Outperform
2 Underperform
 

Wall Street

4 Outperform
0 Underperform
 

Top ENTA Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

Thrifty1 (< 20)
Submitted April 13, 2014

Royalty stream from abbvie likely significant. tiny company with 44 employees and low cash burn rate. Hep C drug looks like it works. They won't be first to market, but probably will have impact.

Top Bear Pitch

There are no pitches that meet the Top Bear criteria. Explain

If this upsets you, start recommending pitches below!

ENTA VS S&P 500 (SPY)

ENTA Summary

Recent Community Commentary

Read the most recent pitches from players about ENTA.

Recs

2
Member Avatar Thrifty1 (< 20) Submitted: 4/12/2014 11:17:34 PM : Outperform Start Price: $33.99 ENTA Score: +121.31

Royalty stream from abbvie likely significant. tiny company with 44 employees and low cash burn rate. Hep C drug looks like it works. They won't be first to market, but probably will have impact.

Recs

1
Member Avatar dbajack2 (90.27) Submitted: 2/10/2014 4:06:30 PM : Outperform Start Price: $38.28 ENTA Score: +87.26

About to break resistance.

Recs

1
Member Avatar PharmTeam (58.64) Submitted: 12/18/2013 10:29:23 AM : Outperform Start Price: $30.66 ENTA Score: +148.32

Enanta's collaboration with Abbvie on a next gen HepC treatment is clearly its main growth driver. That drug will face some serious competition from Gilead's Sovaldi, but with pretty comparable cure rates it will be up to payers to decide which drug to go with. Gilead's solid results today sent ENTA down 14% to a market cap of only 500M and change, making for a good entry point.

Leaderboard

Find the members with the highest scoring picks in ENTA.

Score Leader

alicedallas

alicedallas (< 20) Score: +389.64

The Score Leader is the player with the highest score across all their picks in ENTA.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
alicedallas < 20 6/17/2013 Outperform 1Y $16.85 +468.43% +78.79% +389.64 0 Comment
This player feels very strongly about this pick and has marked it a Top Pick. Top Picks do not affect a player’s score. efarev 98.62 7/19/2013 Outperform 5Y $17.56 +445.44% +73.61% +371.84 0 Comment
tpc2104 < 20 9/9/2013 Outperform 3Y $18.70 +412.19% +76.37% +335.82 0 Comment
pbtoau78 56.82 9/5/2013 Outperform 5Y $18.75 +410.83% +77.01% +333.82 0 Comment
BrianNichols 91.27 4/25/2013 Outperform 5Y $18.56 +416.06% +85.18% +330.87 0 Comment
lemny 26.82 6/7/2013 Outperform 5Y $18.89 +407.04% +78.57% +328.48 0 Comment
zzlangerhans 99.60 9/3/2013 Outperform 1Y $18.95 +405.44% +77.75% +327.69 2 Comments
This player feels very strongly about this pick and has marked it a Top Pick. Top Picks do not affect a player’s score. projectchris 49.37 11/4/2013 Outperform 5Y $20.13 +375.81% +66.15% +309.66 0 Comment
portefeuille4 99.71 9/2/2016 Outperform 5Y $22.12 +333.10% +34.61% +298.49 0 Comment
MoolaMonster 66.22 11/20/2013 Outperform 5Y $21.20 +351.79% +63.59% +288.21 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Player Name Player
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
S&P
Gain
Score End Date Commentary
TrackJMP 83.50 10/23/2015 Outperform NS $24.14 +296.77% +41.65% +255.12 0 Comment
TrackJGreenblatt 56.76 5/28/2015 Outperform 1Y $40.43 +136.90% +38.31% +98.59 1 Comment
TrackFBRCapitalM 86.16 8/15/2014 Outperform NS $40.52 +136.38% +49.42% +86.95 0 Comment
TrackCreditSuiss 89.13 4/16/2013 Outperform NS $21.57 +344.04% +87.84% +256.21 0 Comment

Featured Broker Partners


Advertisement